Clinical Trial Update: A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis [Phase 1, Phase 2]

View source ↗

Summary

Krystal Biotech is conducting a Phase 1/2 trial to compare KB801 with placebo in patients with Stage 2 or Stage 3 neurotrophic keratitis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurotrophic Keratitis

Drugs mentioned

• KB801

Snippet

Sponsor: Krystal Biotech, Inc. | Conditions: Neurotrophic Keratitis | Phase 1, Phase 2 | Status: RECRUITING